Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma-Reference-Cited by-同舟云学术

Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma

Published:2021-05-24 Issue:7 Volume:21 Page:863-873
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Wong Jeffrey L.¹²^ORCID,Rosenberg Jonathan E.¹³

Affiliation:

1. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2. b Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY, USA

3. Department of Medicine, Weill Cornell Medical College, New York, NY, USA

Funder

National Cancer Institute, National Institutes of Health (NIH), through the Memorial Sloan Kettering (MSK) Specialized Program of Research Excellence in Bladder Cancer

MSK Cancer Center Support

NIH National Center for Advancing Translational Sciences

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1929168

Reference88 articles.

1. Cancer Statistics, 2021

2. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection

3. Bladder cancer

4. Cancer statistics, 2020

5. Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-Drug Conjugates in Urothelial Cancer: From Scientific Rationale to Clinical Development;Cancers;2024-06-30

2. Antibody-drug conjugates in solid tumors: a new frontier;Current Opinion in Oncology;2024-06-19

3. The combination of immune checkpoint inhibitors and antibody-drug conjugates in the treatment of urogenital tumors: a review insights from phase 2 and 3 studies;Cell Death & Disease;2024-06-19

4. Progress in the study of antibody-drug conjugates for the treatment of cervical cancer;Frontiers in Oncology;2024-06-06

5. Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with⁶⁸Ga-N188;Journal of Nuclear Medicine;2024-05